Safety and Efficacy study of ONGLYZA (Saxagliptin) under conditions of actual use - ONGLYZA PMS

Study identifier:NIS-CPH-DUM-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A descriptive study of the efficacy and safety of ONGLYZA (Saxagliptin) under conditions of actual use in the Philippines

Medical condition

Type 2 Diabetes Mellitus

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

542

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria